Market Research Logo

Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )

Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich nations will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market.

Kalorama's Pharmaceutical Markets in Brazil, Russia, India and China (BRIC nations) takes a solid look at opportunities available for pharmaceutical companies in these emerging markets, including the following information:

  • Competitive Activity
  • Current Market Size
  • Forecast to 2012
  • Population, Economy and Demographics
  • Health Indicators for each Country
  • Market Trends
  • Company Profiles
What economic and demographic factors are driving companies to this market? Who are the major players having success in this area? What should companies know about each country's healthcare system in order to plan their strategy. For each country, this report answers these questions and analyzes markets a look at the following specific segments
  • Cardiovascular Drugs
  • Gastrointestinal Drugs
  • Infection control Drugs
  • Neurotherapeutics/CNS Drugs
  • Oncology Drugs
  • Respiratory Drugs
  • Others

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 80 key industry officials, consultants, health care providers, and government personnel.

These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.


  • Executive Summary
    • OVERVIEW
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
    • KEY ISSUES AND TRENDS AFFECTING THE MARKET
    • LEADING COMPETITORS
  • Introduction
    • OVERVIEW
    • INTELLECTUAL PROPERTY RIGHTS AND COMPULSORY LICENSING
    • BIOSIMILAR PRODUCTION
    • ETHICAL ISSUES REGARDING DTC ADVERTISING IN DEVELOPING REGIONS
    • WORLD HEALTH
      • Tobacco Use
        • Table Percent of Smokers by Country, Adult Population 15+
      • Obesity
        • Table Percent of Population that is Obese*, Estimated 2005 (%)
    • WORLD ECONOMIC TRENDS
      • Table Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
      • Purchasing Power Trends
        • Table Gross National Income Comparison by Country 2000-2005
  • Pharmaceutical Markets in India
    • OVERVIEW AND SUMMARY
      • Table India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012 (in millions of dollars at the manufacturers' level)
      • Table India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
    • REGULATORY ENVIRONMENT
    • ECONOMIC DEVELOPMENT
      • Table India's Economic Profile
      • Table Gross National Income Per Capita and Growth Comparison for 2005 and 2006
    • HEALTHCARE TRENDS IN INDIA
      • Healthcare Professionals
        • Table Healthcare Professionals in India by Type, Estimated 2004 and 2007
    • DEMOGRAPHICS
      • Table India - Midyear Population, by Age and Sex 2007 and 2012 (millions of population)
      • Birth Rates
        • Table India Fertility Rates and Births Estimated 2005, 2007; Projected 2008, 2025
      • Life Expectancy
        • Table India Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
      • Mortality
        • Table India Mortality Rates and Numbers Estimated 2005, 2007; Projected 2008, 2025
        • Table India Leading Causes of Death, Estimated 2007
    • KEY PRODUCT SEGMENTS AND MARKET INDICATORS
      • Table HIV Indicators, India
      • Table Tuberculosis Surveillance and Epidemiology, India Burden Estimate 2006 Estimate 2007
      • Table India Malaria Data, 1990-2003
      • Table Cancer Surveillance and Epidemiology, India
      • Table Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World Cancer Type Incidence Percent of World
    • MARKET ANALYSIS
      • Table India Pharmaceutical Market Analysis, 2005-2007 (in millions of dollars at the manufacturers' level)
      • Table Forecasted India Pharmaceutical Market Analysis: 2008-2012 (in millions of dollars at the manufacturers' level)
      • Product Segment Market Analysis
        • Table India Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012 (in millions of dollars at the manufacturers' level)
        • Table India Pharmaceutical Market Analysis by Product Segment, 2007
        • Table India Pharmaceutical Market Forecast by Product Segment, 2012
      • Competitive Outlook and Distribution
        • Table Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007
  • Pharmaceutical Markets in China
    • OVERVIEW AND SUMMARY
      • Table China Pharmaceutical Market as a Percentage of World Market, 2007 and 2012 (in millions of dollars at the manufacturers' level)
      • Table China Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
    • REGULATORY ENVIRONMENT
      • Table Chinese and U.S. Drug Review Timeline
    • ECONOMIC DEVELOPMENT
      • Table China's Economic Profile
      • Table Gross National Income Per Capita and Growth Comparison for 2005 and 2006
    • HEALTHCARE TRENDS IN CHINA
      • Healthcare Professionals
        • Table Healthcare Professionals in China by Type, Estimated 2004 and 2007
    • DEMOGRAPHICS
      • Table China - Midyear Population, by Age and Sex 2007 and 2012 (millions of population)
      • Birth Rates
        • Table China Fertility Rates and Births Estimated 2005, 2007; Projected 2008, 2025
      • Life Expectancy
        • Table China Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
      • Mortality
        • Table China Mortality Rates and Numbers Estimated 2005, 2007; Projected 2008, 2025
        • Table China Leading Causes of Death, Estimated 2007
    • KEY PRODUCT SEGMENTS AND MARKET INDICATORS
      • Table HIV Indicators, China Indicator Estimate 2005
      • Table Tuberculosis Surveillance and Epidemiology, China
      • Table China Malaria Data, 1990-2003
      • Table Cancer Surveillance and Epidemiology, China
      • Table Estimated Cancer Incidence in China by Most Common Types of Cancer, Compared to World, 2007
    • MARKET ANALYSIS
      • Table China Pharmaceutical Market Analysis, 2005-2007 (in millions of dollars at the manufacturers' level)
      • Table Forecasted China Pharmaceutical Market Analysis: 2008-2012 (in millions of dollars at the manufacturers' level)
      • Product Segment Market Analysis
        • Table China Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012 (in millions of dollars at the manufacturers' level)
        • Table China Pharmaceutical Market Analysis by Product Segment, 2007
        • Table China Pharmaceutical Market Forecast by Product Segment, 2012
      • Competitor Outlook and Distribution
        • Table Estimated Sales of Pharmaceuticals in China by Local and Foreign Suppliers, 2007
  • Pharmaceutical Markets in Russia
    • OVERVIEW AND SUMMARY
      • Table Russia Pharmaceutical Market as a Percentage of World Market, 2007 and 2012 (in millions of dollars at the manufacturers' level)
      • Table Russia Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
    • REGULATORY ENVIRONMENT
    • ECONOMIC DEVELOPMENT
      • Table Russia's Economic Profile
      • Table Gross National Income Per Capita and Growth Comparison for 2005 and 2006
    • HEALTHCARE TRENDS IN RUSSIA
      • Healthcare Professionals
        • Table Healthcare Professionals in Russia by Type, Estimated 2004 and 2007
    • DEMOGRAPHICS
      • Table Russia - Midyear Population, by Age and Sex 2007 and 2012 (millions of population)
      • Birth Rates
        • Table Russia Fertility Rates and Births Estimated 2005, 2007; Projected 2008, 2025
      • Life Expectancy
        • Table Russia Life Expectancy at Birth, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
      • Mortality
        • Table Russia Mortality Rates and Numbers Estimated 2005, 2007; Projected 2008, 2025
        • Table Russia Leading Causes of Death, Estimated 2007
    • KEY PRODUCT SEGMENTS AND MARKET INDICATORS
      • Table HIV Indicators, Russia
      • Table Tuberculosis Surveillance and Epidemiology, Russia
      • Table Cancer Surveillance and Epidemiology, Russia
      • Table Estimated Cancer Incidence in Russia by Most Common Types of Cancer, Compared to World, 2007
    • MARKET ANALYSIS
      • Table Russia Pharmaceutical Market Analysis, 2005-2007 (in millions of dollars at the manufacturers' level)
      • Table Forecasted Russia Pharmaceutical Market Analysis: 2008-2012 (in millions of dollars at the manufacturers' level)
      • Product Segment Market Analysis
        • Table Russia Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012 (in millions of dollars at the manufacturers' level)
        • Table Russia Pharmaceutical Market Analysis by Product Segment, 2007
        • Table Russia Pharmaceutical Market Forecast by Product Segment, 2012
      • Competitive Outlook and Distribution
        • Table Estimated Sales of Pharmaceuticals in Russia by Local and Foreign Suppliers, 2007
  • Pharmaceutical Markets in Brazil
    • OVERVIEW AND SUMMARY
      • Table Brazil Pharmaceutical Market as a Percentage of World Market, 2007 and 2012 (in millions of dollars at the manufacturers' level)
      • Table Brazil Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
    • REGULATORY ENVIRONMENT
    • ECONOMIC DEVELOPMENT
      • Table Brazil's Economic Profile
      • Table Gross National Income Per Capita and Growth Comparison for 2005 and 2006
    • HEALTHCARE TRENDS IN BRAZIL
      • Healthcare Professionals
        • Table Healthcare Professionals in Brazil by Type, Estimated 2004 and 2007
    • DEMOGRAPHICS
      • Table Brazil - Midyear Population, by Age and Sex 2007 and 2012 (millions of population)
      • Birth Rates
        • Table Brazil Fertility Rates and Births Estimated 2005, 2007; Projected 2008, 2025
      • Life Expectancy
        • Table Brazil Life Expectancy at Birth, 2000, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025 Life Expectancy (in years)
      • Mortality
        • Table Brazil Mortality Rates and Numbers Estimated 2005, 2007; Projected 2008, 2025
        • Table Brazil Leading Causes of Death, Estimated 2007
    • KEY PRODUCT SEGMENTS AND MARKET INDICATORS
      • Table Tuberculosis Surveillance and Epidemiology, Brazil
      • Table HIV Indicators, Brazil
      • Table Brazil Malaria Data, 1990-2003
      • Table Cancer Surveillance and Epidemiology, Brazil
      • Table Estimated Cancer Incidence in Brazil by Most Common Types of Cancer, Compared to World
    • MARKET ANALYSIS
      • Table Brazil Pharmaceutical Market Analysis, 2005-2007 (in millions of dollars at the manufacturers' level)
      • Table Forecasted Brazil Pharmaceutical Market Analysis: 2008-2012 (in millions of dollars at the manufacturers' level)
      • Product Segment Market Analysis
        • Table Brazil Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012 (in millions of dollars at the manufacturers' level)
        • Table Brazil Pharmaceutical Market Analysis by Product Segment, 2007
        • Table Brazil Pharmaceutical Market Forecast by Product Segment, 2012
      • Competitive Outlook and Distribution
        • Table Estimated Sales of Pharmaceuticals in Brazil by Local and Foreign Suppliers, 2007
  • Market Summary
    • OVERVIEW
      • Table BRIC Market Analysis, 2005-2007 (in billions of dollars at the manufacturers' level)
      • Table Forecasted BRIC Market Analysis: 2008-2012 (in billions of dollars at the manufacturers' level)
      • Markets by Country
        • Table World Pharmaceutical Markets by Country/Region, 2007
  • Global Leaders
    • OVERVIEW
      • ASTRA ZENECA
      • GLAXOSMITHKLINE
      • NOVARTIS AG
      • PFIZER, INC.
      • ROCHE
      • SANOFI-AVENTIS
  • List of Major Companies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report